CL2007000529A1 - Antigeno vacunal quimerico contra el virus de la peste porcina clasica, vppc, que contiene el segmento extracelular de la glicoproteina e2 de la envoltura viral del vppc y una proteina estimuladora del sistema inmune cd154; composicion que lo comprende. - Google Patents
Antigeno vacunal quimerico contra el virus de la peste porcina clasica, vppc, que contiene el segmento extracelular de la glicoproteina e2 de la envoltura viral del vppc y una proteina estimuladora del sistema inmune cd154; composicion que lo comprende.Info
- Publication number
- CL2007000529A1 CL2007000529A1 CL2007000529A CL2007000529A CL2007000529A1 CL 2007000529 A1 CL2007000529 A1 CL 2007000529A1 CL 2007000529 A CL2007000529 A CL 2007000529A CL 2007000529 A CL2007000529 A CL 2007000529A CL 2007000529 A1 CL2007000529 A1 CL 2007000529A1
- Authority
- CL
- Chile
- Prior art keywords
- vppc
- glycoprotein
- composition
- immune system
- understands
- Prior art date
Links
- 241000710777 Classical swine fever virus Species 0.000 title abstract 2
- 108090000288 Glycoproteins Proteins 0.000 title abstract 2
- 102000003886 Glycoproteins Human genes 0.000 title abstract 2
- 108010003533 Viral Envelope Proteins Proteins 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 210000000987 immune system Anatomy 0.000 title abstract 2
- 210000004779 membrane envelope Anatomy 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 230000004936 stimulating effect Effects 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Treatment Of Fiber Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Antígeno vacunal quimérico contra el virus de la peste porcina clásica, vppc, que contiene el segmento extracelular de la glicoproteína e2 de la envoltura viral del vppc y una proteína estimuladora del sistema inmune; y composición que lo comprende.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20060052A CU23544A1 (es) | 2006-02-28 | 2006-02-28 | Antígenos vacunales quiméricos contra el virus de la peste porcina clásica |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2007000529A1 true CL2007000529A1 (es) | 2008-01-18 |
Family
ID=38279009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2007000529A CL2007000529A1 (es) | 2006-02-28 | 2007-02-27 | Antigeno vacunal quimerico contra el virus de la peste porcina clasica, vppc, que contiene el segmento extracelular de la glicoproteina e2 de la envoltura viral del vppc y una proteina estimuladora del sistema inmune cd154; composicion que lo comprende. |
Country Status (17)
Country | Link |
---|---|
US (1) | US8409562B2 (es) |
EP (1) | EP1994943B1 (es) |
JP (1) | JP5190383B2 (es) |
KR (1) | KR101506979B1 (es) |
CN (2) | CN101426525A (es) |
AR (1) | AR059648A1 (es) |
AT (1) | ATE490782T1 (es) |
BR (1) | BRPI0708354B1 (es) |
CA (1) | CA2638830C (es) |
CL (1) | CL2007000529A1 (es) |
CU (1) | CU23544A1 (es) |
DE (1) | DE602007011042D1 (es) |
ES (1) | ES2357563T3 (es) |
HK (1) | HK1219052A1 (es) |
MX (1) | MX2008011144A (es) |
RU (1) | RU2406534C2 (es) |
WO (1) | WO2007098717A2 (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10307475B2 (en) | 2009-03-27 | 2019-06-04 | Academia Sinica | Methods and compositions for immunization against virus |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI362416B (en) * | 2008-07-31 | 2012-04-21 | Mao Xing Biolog Technology Co Ltd | Yeast expressed classical swine fever virus glycoprotein e2 and use thereof |
WO2017195919A1 (ko) * | 2016-05-12 | 2017-11-16 | 주식회사 바이오앱 | 식물 유래의 돼지 열병 백신용 조성물 및 이의 제조방법 |
WO2020215266A1 (zh) * | 2019-04-25 | 2020-10-29 | 财团法人农业科技研究院 | 预防猪瘟病毒感染的重组蛋白质及含其的组合物及细胞 |
CU20210070A7 (es) * | 2021-08-20 | 2023-03-07 | Ct Ingenieria Genetica Biotecnologia | Antígenos quiméricos para el control de coronavirus y composiciones que los comprenden |
CN114835822B (zh) * | 2022-04-22 | 2022-11-04 | 浙江洪晟生物科技股份有限公司 | 猪瘟病毒的多聚体疫苗及其制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4542225A (en) * | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
ZA901719B (en) | 1989-03-19 | 1991-01-30 | Akzo Nv | Hog cholera virus vaccine and diagnostics |
US5651972A (en) | 1989-04-21 | 1997-07-29 | University Of Florida Research Foundation, Inc. | Use of recombinant swine poxvirus as a live vaccine vector |
EP0924298A1 (en) | 1997-12-18 | 1999-06-23 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Protein expression in baculovirus vector expression systems |
FR2804028B1 (fr) | 2000-01-21 | 2004-06-04 | Merial Sas | Vaccins adn ameliores pour animaux de rente |
WO2001083737A2 (en) | 2000-05-03 | 2001-11-08 | University Of Guelph | Porcine adenovirus type 5 vector and vaccine |
RU2183972C2 (ru) | 2000-07-13 | 2002-06-27 | ВНИИ ветеринарной вирусологии и микробиологии | Способ получения высокоактивной специфической к вирусу классической чумы свиней сыворотки крови свиней |
CN1338309A (zh) | 2000-08-10 | 2002-03-06 | 清华大学 | 一种合成肽猪瘟疫苗及其制备方法 |
RU2182495C1 (ru) | 2001-05-03 | 2002-05-20 | Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных | Вирусвакцина против классической чумы свиней |
US20040096457A1 (en) * | 2001-12-11 | 2004-05-20 | Huber Brigitte T | Treatment and prevention of ebv infection and ebv-associated disorders |
CU23102A1 (es) * | 2002-10-21 | 2005-12-20 | Ct Ingenieria Genetica Biotech | Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos |
US7183384B2 (en) * | 2003-03-06 | 2007-02-27 | A & G Pharmaceutical, Inc. | Monoclonal antibody 7H11 reactive with human cancer |
EP1522585A1 (en) | 2003-10-09 | 2005-04-13 | Plant Research International B.V. | Chimeric carrier molecules for the production of mucosal vaccines |
-
2006
- 2006-02-28 CU CU20060052A patent/CU23544A1/es active IP Right Grant
-
2007
- 2007-02-27 AR ARP070100808A patent/AR059648A1/es active IP Right Grant
- 2007-02-27 CL CL2007000529A patent/CL2007000529A1/es unknown
- 2007-02-28 US US12/280,055 patent/US8409562B2/en active Active
- 2007-02-28 CN CNA2007800146285A patent/CN101426525A/zh active Pending
- 2007-02-28 CA CA2638830A patent/CA2638830C/en active Active
- 2007-02-28 ES ES07711102T patent/ES2357563T3/es active Active
- 2007-02-28 CN CN201510530087.8A patent/CN105214081A/zh active Pending
- 2007-02-28 RU RU2008138536/10A patent/RU2406534C2/ru active
- 2007-02-28 EP EP07711102A patent/EP1994943B1/en active Active
- 2007-02-28 KR KR1020087023580A patent/KR101506979B1/ko active IP Right Grant
- 2007-02-28 AT AT07711102T patent/ATE490782T1/de not_active IP Right Cessation
- 2007-02-28 MX MX2008011144A patent/MX2008011144A/es active IP Right Grant
- 2007-02-28 JP JP2008556644A patent/JP5190383B2/ja active Active
- 2007-02-28 WO PCT/CU2007/000008 patent/WO2007098717A2/es active Search and Examination
- 2007-02-28 BR BRPI0708354A patent/BRPI0708354B1/pt active IP Right Grant
- 2007-02-28 DE DE602007011042T patent/DE602007011042D1/de active Active
-
2016
- 2016-06-21 HK HK16107128.2A patent/HK1219052A1/zh unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10307475B2 (en) | 2009-03-27 | 2019-06-04 | Academia Sinica | Methods and compositions for immunization against virus |
US11672853B2 (en) | 2009-03-27 | 2023-06-13 | Academia Sinica | Methods and compositions for immunization against virus |
Also Published As
Publication number | Publication date |
---|---|
DE602007011042D1 (de) | 2011-01-20 |
CN105214081A (zh) | 2016-01-06 |
RU2008138536A (ru) | 2010-04-10 |
BRPI0708354A2 (pt) | 2011-05-24 |
HK1219052A1 (zh) | 2017-03-24 |
CA2638830A1 (en) | 2007-09-07 |
CN101426525A (zh) | 2009-05-06 |
ES2357563T3 (es) | 2011-04-27 |
MX2008011144A (es) | 2009-01-26 |
JP5190383B2 (ja) | 2013-04-24 |
RU2406534C2 (ru) | 2010-12-20 |
KR101506979B1 (ko) | 2015-03-30 |
JP2009528304A (ja) | 2009-08-06 |
CU23544A1 (es) | 2010-06-17 |
BRPI0708354B1 (pt) | 2016-04-19 |
AR059648A1 (es) | 2008-04-16 |
EP1994943A2 (en) | 2008-11-26 |
ATE490782T1 (de) | 2010-12-15 |
WO2007098717A2 (es) | 2007-09-07 |
US8409562B2 (en) | 2013-04-02 |
EP1994943B1 (en) | 2010-12-08 |
CA2638830C (en) | 2015-04-14 |
KR20080111023A (ko) | 2008-12-22 |
WO2007098717A3 (es) | 2007-11-01 |
US20090304633A1 (en) | 2009-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007000526A1 (es) | Antigeno vacunal quimerico contra el virus de la influenza aviar, ia, que contiene el segmento extracelular de la hemaglutinina de la envoltura del virus de ia y el segmento extracelular de la proteina cd154; y composicion que lo comprende. | |
BR112019014986A2 (pt) | anticorpo que alveja bcma e uso do mesmo | |
CY1123783T1 (el) | Antiσωμαta enanti-b7-h3 και συζευγματα αντισωματος φαρμακου | |
CY1120328T1 (el) | Συνθεση εμβολιου περιεχουσα συνθετικο ανοσοενισχυτικο | |
CY1121535T1 (el) | Πρωτεϊνικα κατασκευασματα uspa2 και χρησεις αυτων | |
CL2007000529A1 (es) | Antigeno vacunal quimerico contra el virus de la peste porcina clasica, vppc, que contiene el segmento extracelular de la glicoproteina e2 de la envoltura viral del vppc y una proteina estimuladora del sistema inmune cd154; composicion que lo comprende. | |
CR20160041A (es) | Proteína de fusión terapéutica | |
ATE552846T1 (de) | Verbesserter grippeimpfstoff | |
UY36304A (es) | Proteínas de fusión, bacterias recombinantes y métodos de uso de las bacterias recombinantes | |
CO6480978A2 (es) | Antigenos de virus de sincicio respiratorio recombinantes | |
CR20120310A (es) | Anticuerpos neutralizadores contra el receptor de prolactina y su uso terapéutico | |
CO2019011640A2 (es) | Métodos y composiciones para la reducción de la inmunogenicidad | |
BR112018075032A2 (pt) | proteínas de hemaglutinina do vírus influenza e seus uso | |
EA201070219A1 (ru) | Полимерные мультиэпитопные вакцины против гриппа | |
UY33297A (es) | Composiciones farmaceuticas que comprenden un polipéptido que comprende al menos un motivo cxxc y antígenos heterólogos y usos de las mismas | |
ES2562774T3 (es) | Vacunas para la gripe basadas en el virus del mosaico de la papaya | |
CL2012003094A1 (es) | Anticuerpo bivalente aislado o fragmento bivalente del mismo, que actua sobre lrp6 potenciando una señal wnt al agrupar uno o mas receptores lrp6 en presencia de una proteina de union de lrp6; acido nucleico que lo codifica; vector que comprende dicho acido nucleico; composicion farmaceutica que comprende un anticuerpo multivalente anti-lrp6; y su uso para tratar cancer. | |
CL2008002092A1 (es) | Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas. | |
AR080313A1 (es) | Composiciones de virus de moquillo canino (cdv) recombinante y sus usos | |
EA201590829A1 (ru) | Новые мукозные адъюванты и системы доставки | |
CO6440541A2 (es) | Virus de diarrea viral bovina con una proteina erns modificada | |
PE20141683A1 (es) | Anticuerpos monoclonales especificos para el antigeno m2-1 del virus respiratorio sincicial (vrs) | |
EA201790558A1 (ru) | Композиция с пониженной иммуногенностью | |
CO7461135A2 (es) | Parvovirus porcino 5b, métodos de uso y vacuna | |
UY31574A1 (es) | Vacunas contra la malaria |